Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.

about

Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.

Item

http://www.wikidata.org/entity/Q47191741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@en

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@nl

type

Item

label

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@en

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@nl

prefLabel

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@en

Postneoadjuvant adjuvant chemo ...... r with residual nodal disease.

@nl

P1476

Postneoadjuvant adjuvant chemo ...... er with residual nodal disease

@en

P2093

Joshua E Rosen

http://www.w3.org/2001/XMLSchema#string

Sarah J Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial

Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database.

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.

Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).

Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database.

Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.

P304

1193-1196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24779

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

James W Smithy

Anthony W Kim

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29314062

http://www.w3.org/2001/XMLSchema#string